THOMAS A BUCHHOLZ to Chemoradiotherapy
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Chemoradiotherapy.
Connection Strength
0.014
-
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec; 30(6):2113-20.
Score: 0.014
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.